endralazine has been researched along with prazosin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Izotov, AI; Malysheva, NV; Postol'nikov, SF | 1 |
| Izotov, AI; Postol'nikov, SF; Vygodin, VA | 1 |
2 trial(s) available for endralazine and prazosin
| Article | Year |
|---|---|
[Endralazine monotherapy in comparison with prazosin and hydralazine in arterial hypertension].
Topics: Adult; Clinical Trials as Topic; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Pyridazines | 1986 |
[Methodologic approach to individual evaluation of the pharmacodynamic effects of single doses of hydralazine, endralazine, prazosine and propranolol in hypertension patients].
Topics: Adult; Antihypertensive Agents; Cardiac Output; Cardiography, Impedance; Humans; Hydralazine; Hypertension; Kinetics; Middle Aged; Prazosin; Propranolol; Pyridazines; Vascular Resistance | 1984 |
2 other study(ies) available for endralazine and prazosin
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |